%0 Journal Article
%T Current development of molecular classifications of gastric cancer based on omics (Review).
%A Ma Y
%A Jiang Z
%A Pan L
%A Zhou Y
%A Xia R
%A Liu Z
%A Yuan L
%J Int J Oncol
%V 65
%N 3
%D 2024 09
%M 39092559
%F 5.884
%R 10.3892/ijo.2024.5677
%X Gastric cancer (GC) is a complex and heterogeneous disease with significant phenotypic and genetic variation. Traditional classification systems rely mainly on the evaluation of clinical pathological features and conventional biomarkers and might not capture the diverse clinical processes of individual GCs. The latest discoveries in omics technologies such as next‑generation sequencing, proteomics and metabolomics have provided crucial insights into potential genetic alterations and biological events in GC. Clustering strategies for identifying subtypes of GC might offer new tools for improving GC treatment and clinical trial outcomes by enabling the development of therapies tailored to specific subtypes. However, the feasibility and therapeutic significance of implementing molecular classifications of GC in clinical practice need to addressed. The present review examines the current molecular classifications, delineates the prevailing landscape of clinically relevant molecular features, analyzes their correlations with traditional GC classifications, and discusses potential clinical applications.